Target intelligence / Profile preview

Severe acute respiratory syndrome coronavirus 2 genomic and subgenomic RNA (SARS-CoV-2 RNA)

Target
SARS-CoV-2 RNA
Molecular classification
Viral RNA, Nucleic acid, Positive-sense single-stranded RNA
01

Overview

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genomic RNA (gRNA) is a single-stranded, positive-sense RNA molecule of approximately 30 kilobases that serves as the primary genetic blueprint for the virus [1]. Upon entering a host cell, the gRNA is translated to produce non-structural proteins that form the replication-transcription complex, which then synthesizes a series of nested subgenomic RNAs (sgRNAs) [2]. These sgRNAs are essential for the translation of structural proteins, such as Spike (S), Envelope (E), Membrane (M), and Nucleocapsid (N), as well as various accessory proteins required for viral pathogenesis and immune evasion [1,3]. As a therapeutic target, the RNA can be directly addressed using antisense oligonucleotides (ASOs) or small interfering RNAs (siRNAs) that trigger degradation or block translation, as well as small molecules that target highly conserved secondary structures like the 5' untranslated region (UTR) or the ribosomal frameshifting element [4]. Drugs like Molnupiravir act by being incorporated into the nascent RNA strand, leading to an accumulation of mutations that render the virus non-functional, a process known as lethal mutagenesis [5]. Targeting the RNA genome is a robust strategy because it can focus on highly conserved regions that are less prone to the mutations seen in surface proteins like the Spike protein [4]. [1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205740/ [2] https://www.nature.com/articles/s41586-020-2277-z [3] https://www.cell.com/cell/fulltext/S0092-8674(20)30462-3 [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415559/ [5] https://www.nature.com/articles/s41586-021-03544-w

Other names
SARS-CoV-2 gRNASARS-CoV-2 sgRNASARS-CoV-2 transcriptomeSevere acute respiratory syndrome coronavirus 2 genome2019-nCoV RNA
02

Mechanism of action

Inhibition of viral replication through chain termination, induction of lethal mutagenesis (error catastrophe), RNA interference (RNAi) mediated degradation, or antisense-mediated steric hindrance of translation and replication.

03

Biological functions

Viral replicationViral translationViral assemblyTemplate for subgenomic mRNA synthesisRibosomal frameshifting
04

Disease associations

InfectionCOVID-19
05

Safety considerations

Off-target binding to host cellular RNASystemic delivery challenges to the respiratory epitheliumPotential for rapid viral evolution and escape mutations in target sequencesInduction of innate immune responses (e.g., interferon) by exogenous RNA
06

Interacting drugs

Molnupiravir

4 more in the full profile.

07

Biomarkers

Viral load (RT-qPCR)Cycle threshold (Ct) valueSubgenomic RNA levels (as a marker of active replication)

Beyond the preview

Go deeper on Severe acute respiratory syndrome coronavirus 2 genomic and subgenomic RNA (SARS-CoV-2 RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Severe acute respiratory syndrome coronavirus 2 genomic and subgenomic RNA (SARS-CoV-2 RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call